Impact of microarray data quality on genomic data submissions to the FDA
- 1 September 2006
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (9), 1105-1107
- https://doi.org/10.1038/nbt0906-1105
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cross-platform comparability of microarray technology: Intra-platform consistency and appropriate data analysis procedures are essentialBMC Bioinformatics, 2005
- QA/QC: challenges and pitfalls facing the microarray community and regulatory agenciesExpert Review of Molecular Diagnostics, 2004
- Pharmacogenomic-guided drug development: regulatory perspectiveThe Pharmacogenomics Journal, 2002
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001